Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment
Tilray Medical, part of Tilray Brands, Inc., is contributing to a clinical trial in Spain to study medical cannabis's efficacy against glioblastoma, a severe brain cancer. The trial involves 30 patients and is a collaboration with GEINO and Complutense University of Madrid, funded by the Medical Cannabis Bike Tour Foundation.
Reference News
Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment
Tilray Medical, part of Tilray Brands, Inc., is contributing to a clinical trial in Spain to study medical cannabis's efficacy against glioblastoma, a severe brain cancer. The trial involves 30 patients and is a collaboration with GEINO and Complutense University of Madrid, funded by the Medical Cannabis Bike Tour Foundation.